Support for developing new cancer drugs and therapies
IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP
['FUNDING_OTHER'] · TECHNICAL RESOURCES INTERNATIONAL, INC. · NIH-11110272
This study is all about helping to create new cancer treatments by making sure everything is done right and safely during the testing process, so that patients can get better options for their care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TECHNICAL RESOURCES INTERNATIONAL, INC. (nih funded) |
| Locations | 1 site (BETHESDA, UNITED STATES) |
| Trial ID | NIH-11110272 on ClinicalTrials.gov |
What this research studies
This research focuses on providing essential support services to the Cancer Therapy Evaluation Program (CTEP) to facilitate the development of new cancer drugs. It involves preparing and submitting necessary documents to the FDA, tracking investigational anti-cancer agents, and monitoring safety and adverse events during clinical trials. By ensuring compliance with regulatory requirements and supporting collaborations with pharmaceutical companies, this initiative aims to streamline the drug development process for cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with cancer who may be eligible for new investigational therapies.
Not a fit: Patients with non-cancerous conditions or those not eligible for clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the faster development and approval of new cancer treatments, improving outcomes for patients.
How similar studies have performed: Previous research has shown success in similar approaches, indicating that structured support for drug development can lead to significant advancements in cancer treatment.
Where this research is happening
BETHESDA, UNITED STATES
- TECHNICAL RESOURCES INTERNATIONAL, INC. — BETHESDA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MILLER, LAUREN — TECHNICAL RESOURCES INTERNATIONAL, INC.
- Study coordinator: MILLER, LAUREN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents, Cancer Drug, Cancer Therapy Evaluation Program